Showing 331-340 of 595 results for "".
GLP-1 Receptor Agonists: Current Roles in Medicine
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-current-roles-in-medicine/48897/In recent years, the popularity of glucagon-like peptide 1 receptor agonists (GLP-1RAs) has skyrocketed, along with interest in clinical applications beyond diabetes and weight management. Here, we present a brief review of GLP-1RAs, including a history, a look at the mechanism of action, pivotal reConsidering Liver Health in Psoriasis: New Assessment Options
https://practicaldermatology.com/topics/psoriasis/considering-liver-health-in-psoriasis-new-assessment-options/23429/A rapid, non-invasive liver exam addresses growing need for early identification and monitoring of liver disease among patients with psoriasis.Look to the EAST: Shared Decision Making in the Era of New Therapies
https://practicaldermatology.com/topics/atopic-dermatitis/look-to-the-east-shared-decision-making-in-the-era-of-new-therapies/23372/Assessing Efficacy, Accessibility, Safety, and Tolerability is the key to a meaningful dialogue with patients.Diet and Inflammation in Dermatology
https://practicaldermatology.com/topics/other-dermatitis/diet-and-inflammation-in-dermatology/23008/Reduce Your Life Insurance Costs
https://practicaldermatology.com/topics/practice-management/reduce-your-life-insurance-costs/20630/You “refi” your mortgage when rates go down. Here are seven reasons to do the same for your life insurance.From Diagnosis to Prognosis: Using MyPath® Melanoma and DecisionDx®-Melanoma to Help Guide Patient Management Decisions
https://reachmd.com/programs/practical-dermatology/from-diagnosis-to-prognosis-using-mypath-melanoma-and-decisiondx-melanoma-to-help-guide-patient-management-decisions/39944/Gene Expression Profile Testing Helps Clinicians Clarify Diagnostically Ambiguous Lesions and Deliver Personalized, Risk-Aligned Melanoma CareA Practical Primer for Dysport, Part 1: Speaking the Language and Strategies for Success with the Glabella and Forehead
https://practicaldermatology.com/topics/general-topics/PD0709_09-php/22804/To gain the most benefit from the newest botulinum neurotoxin, clinicians need to think about the product in its own terms.Racism in Medicine and the Problem of Health Care Disparities
https://practicaldermatology.com/topics/skin-of-color/racism-in-medicine-and-the-problem-of-health-care-disparities/23761/Dermatologists can work to improve health outcomes for all patients.New Rosacea Classification System Encourages
More Precise Assessment and Treatmenthttps://practicaldermatology.com/topics/practice-management/new-rosacea-classification-system-encourages-br-more-precise-assessment-and-treatment/20484/A look at the rationale behind the new classification system and what it means for clinicians.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21006/